Walleye Capital LLC Cin Cor Pharma, Inc. Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$10.75 - $29.84 $1.24 Million - $3.44 Million
-115,160 Reduced 91.16%
11,166 $137,000
Q3 2022

Nov 14, 2022
BUY
$19.9 - $38.94 $1.93 Million - $3.78 Million
97,003 Added 330.81%
126,326 $4.15 Million
Q2 2022

Aug 08, 2022
BUY
$13.67 - $25.74 $14,667 - $27,619
1,073 Added 3.8%
29,323 $552,000
Q1 2022

May 16, 2022
BUY
$14.13 - $28.49 $399,172 - $804,842
28,250 New
28,250 $496,000

Others Institutions Holding CINC

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CinCor Pharma, Inc.

CINC Quotes by TradingView
  • Ticker CINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,764,300
  • Description
  • CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...
More about CINC
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email